Related Experiment Videos
[Cardiac arrhythmias in pregnancy]
1Medizinische Klinik II (Schwerpunkete Kardiologie und Angiologie) Universitätsklinik Marienhospital, Ruhr-Universität Bochum, Hölkeskampring 40, 44625 Herne.
Zeitschrift Fur Kardiologie
|May 26, 2001
Summary
Pregnancy requires modified cardiac arrhythmia management, prioritizing maternal and fetal safety. Treatment strategies adapt standard protocols to protect both patient and fetus until delivery.
Area of Science:
- Cardiology
- Obstetrics
- Pharmacology
Context:
- Cardiac arrhythmias are common during pregnancy.
- Management requires adaptation of standard protocols.
- Maternal and fetal well-being are paramount.
Purpose:
- To outline modified treatment strategies for cardiac arrhythmias in pregnant patients.
- To ensure safety for both mother and fetus during pregnancy and delivery.
Summary:
- Atrial and ventricular arrhythmias are discussed, with varying frequencies during pregnancy.
- Acute management includes electrical cardioversion for unstable patients and vagal maneuvers or adenosine for stable supraventricular tachycardia.
- Long-term therapy involves beta-blockers, with alternatives like class Ic agents or sotalol.
- Malignant ventricular arrhythmias necessitate cardioversion or antiarrhythmic drugs, with ICD implantation for specific cases.
- Symptomatic bradycardia may require pacemaker implantation.
- Treatment aims to stabilize the patient and fetus until delivery, allowing for definitive therapy postpartum.
Impact:
- Provides guidance for managing pregnant patients with cardiac arrhythmias.
- Highlights the importance of tailoring treatment to protect the fetus.
- Informs clinical practice regarding pharmacological and electrical interventions during pregnancy.